高鈣血症治療的全球市場:各藥物類型(雙磷酸鹽,抑鈣素,糖皮質激素,Denosumab,擬鈣劑,其他),各適應症,各流通管道,各地區-規模,佔有率,展望,機會分析(2021年~2028年)
市場調查報告書
商品編碼
1069141

高鈣血症治療的全球市場:各藥物類型(雙磷酸鹽,抑鈣素,糖皮質激素,Denosumab,擬鈣劑,其他),各適應症,各流通管道,各地區-規模,佔有率,展望,機會分析(2021年~2028年)

Hypercalcemia Treatment Market, by Drug Type (Bisphosphonates, Calcitonin, Glucocorticoids, Denosumab, Calcimimetics, and Others), by Indication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 219 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於高鈣血症治療藥的法規當局的核準增加,預計促進在預測期間內的市場成長。

本報告提供全球高鈣血症治療市場的相關調查,市場展望,市場動態,市場分析,競爭情形等全面性資訊。

目錄

第1章 調查目的、前提條件

第2章 市場展望

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場概述:各藥物類型
    • 市場概述:各適應症
    • 市場概述:各流通管道
    • 市場概述:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,及趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的開發
  • 開發平台分析
  • PEST分析
  • 法規情境
  • 新產品的銷售/核准
  • 流行病學
  • 市場趨勢

第4章 全球高鈣血症治療市場-COVID-19影響分析

  • 經濟影響
  • COVID-19流行病學
  • 臨床試驗及醫藥品開發的影響
  • 為對抗COVID-19的政府舉措

第5章 全球高鈣血症治療市場:各藥物類型(100萬美元)(2017年~2028年)

  • 概要
  • 雙磷酸鹽
  • 抑鈣素
  • 糖皮質素
  • Denosumab
  • 鈣受體
  • 其他

第6章 全球高鈣血症治療市場:各適應症(100萬美元)(2017年~2028年)

  • 概要
  • 原發性甲狀腺功能亢進症
  • 惡性腫瘤的高鈣血症
  • 其他

第7章 全球高鈣血症治療市場:各銷售管道(100萬美元)(2017年~2028年)

  • 概要
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第8章 全球高鈣血症治療市場:各地區(100萬美元)(2017年~2028年)

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭情形

    • Bayer AG
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Pfizer, Inc.
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Novartis AG
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Dr. Reddy's Laboratories Ltd.
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Amgen Inc.
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Viatris Inc. (Mylan N.V.)
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Sun Pharmaceutical Industries Ltd.
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Cipla Inc.
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Actiza Pharmaceutical Pvt. Ltd.
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Apotex Inc.
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Crinetics Pharmaceuticals, Inc.
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Alkem Labs
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Torrent Pharmaceuticals Ltd.
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Glenmark Pharmaceuticals Ltd.
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Hikma Pharmaceuticals
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略
    • Slate Run Pharmaceuticals
    • 企業的亮點
    • 產品系列
    • 主要的焦點
    • 財務成果
    • 市場策略

第10章 Section

簡介目錄
Product Code: CMI3504

Hypercalcemia is a condition in which the blood calcium concentration is high. Calcium is important for carrying out normal functions of organs, muscles, cells, and nerves. It has a role in blood clotting and bone health as well. Hypercalcemia can make it hard for the body to carry out its normal functions. Extremely high levels of calcium can be life-threatening. Excess parathyroid hormone (PTH) is the main cause of hypercalcemia. If the patient is symptomatic or if the calcium level is higher than 15 mg/dL, even in asymptomatic patients, treatment for hypercalcemia is required. Increased extracellular fluid clearance, reduced gastrointestinal (GI) absorption, and decreased bone resorption are the goals of treating hypercalcemia.

Market Dynamics

The increasing regulatory approvals for hypercalcemia drugs are expected to drive the market growth during the forecast period. For instance, in November 2021, Endo International plc, a pharmaceutical company, announced that the shipping of its calcitonin salmon injection, USP, multi-dose vials (2 mL) had begun by its Par Sterile Products business. Moreover, it started shipping following the final U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application. Par's calcitonin salmon injection is therapeutically equivalent to the MIACALCIN injection provided by Viatris Inc., a global pharmaceutical company. The injection is intended for the early treatment of hypercalcemic emergencies when a rapid reduction in serum calcium is needed, in combination with other appropriate agents.

Key features of the study:

  • This report provides in-depth analysis of the global hypercalcemia treatment market , and provides market size (US$ million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global hypercalcemia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bayer AG, Pfizer, Inc., Novartis AG, Dr. Reddy's Laboratories Ltd., Amgen Inc., Viatris Inc. (Mylan N.V.), Sun Pharmaceutical Industries Ltd., Cipla Inc., Actiza Pharmaceutical Pvt. Ltd., Apotex Inc., Crinetics Pharmaceuticals, Inc., Alkem Labs, Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals, and Slate Run Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global hypercalcemia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hypercalcemia treatment market

Detailed Segmentation:

  • Global Hypercalcemia Treatment Market, By Drug Type:
    • Bisphosphonates
      • Clodronate
      • Etidronate
      • Ibandronate
      • Pamidronate
      • Zoledronic Acid
    • Calcitonin
    • Glucocorticoids
    • Denosumab
    • Calcimimetics
    • Others
  • Global Hypercalcemia Treatment Market, By Indication:
    • Primary Hyperthyroidism
    • Hypercalcemia of Malignancy
    • Others
  • Global Hypercalcemia Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Hypercalcemia Treatment Market, By Region:
    • North America
      • Drug Type
      • Bisphosphonates
      • Clodronate
      • Etidronate
      • Ibandronate
      • Pamidronate
      • Zoledronic Acid
      • Calcitonin
      • Glucocorticoids
      • Denosumab
      • Calcimimetics
      • Others
      • By Indication
      • Primary Hyperthyroidism
      • Hypercalcemia of Malignancy
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • U.S.
      • Canada
    • Latin America
      • Drug Type
      • Bisphosphonates
      • Clodronate
      • Etidronate
      • Ibandronate
      • Pamidronate
      • Zoledronic Acid
      • Calcitonin
      • Glucocorticoids
      • Denosumab
      • Calcimimetics
      • Others
      • By Indication
      • Primary Hyperthyroidism
      • Hypercalcemia of Malignancy
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Drug Type
      • Bisphosphonates
      • Clodronate
      • Etidronate
      • Ibandronate
      • Pamidronate
      • Zoledronic Acid
      • Calcitonin
      • Glucocorticoids
      • Denosumab
      • Calcimimetics
      • Others
      • By Indication
      • Primary Hyperthyroidism
      • Hypercalcemia of Malignancy
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • Drug Type
      • Bisphosphonates
      • Clodronate
      • Etidronate
      • Ibandronate
      • Pamidronate
      • Zoledronic Acid
      • Calcitonin
      • Glucocorticoids
      • Denosumab
      • Calcimimetics
      • Others
      • By Indication
      • Primary Hyperthyroidism
      • Hypercalcemia of Malignancy
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • Drug Type
      • Bisphosphonates
      • Clodronate
      • Etidronate
      • Ibandronate
      • Pamidronate
      • Zoledronic Acid
      • Calcitonin
      • Glucocorticoids
      • Denosumab
      • Calcimimetics
      • Others
      • By Indication
      • Primary Hyperthyroidism
      • Hypercalcemia of Malignancy
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • Drug Type
      • Bisphosphonates
      • Clodronate
      • Etidronate
      • Ibandronate
      • Pamidronate
      • Zoledronic Acid
      • Calcitonin
      • Glucocorticoids
      • Denosumab
      • Calcimimetics
      • Others
      • By Indication
      • Primary Hyperthyroidism
      • Hypercalcemia of Malignancy
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Bayer AG
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer, Inc.
    • Novartis AG
    • Dr. Reddy's Laboratories Ltd.
    • Amgen Inc.
    • Viatris Inc. (Mylan N.V.)
    • Sun Pharmaceutical Industries Ltd.
    • Cipla Inc.
    • Actiza Pharmaceutical Pvt. Ltd.
    • Apotex Inc.
    • Crinetics Pharmaceuticals, Inc.
    • Alkem Labs
    • Torrent Pharmaceuticals Ltd.
    • Glenmark Pharmaceuticals Ltd.
    • Hikma Pharmaceuticals
    • Slate Run Pharmaceuticals

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Indication
    • Market Snapshot, By Distribution
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Developments
  • Pipeline Analysis
  • PEST Analysis
  • Regulatory Scenario
  • New Product Launch/Approval
  • Epidemiology
  • Market Trends

4. Global Hypercalcemia Treatment Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact On Clinical Trial And Drug Development
  • Government Initiatives To Combat COVID-19

5. Global Hypercalcemia Treatment Market, By Drug Type, 2017 - 2028, (US$ Million)

  • Overview
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Bisphosphonates
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Clodronate
    • Etidronate
    • Ibandronate
    • Pamidronate
    • Zoledronic Acid
  • Calcitonin
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Glucocorticoids
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Denosumab
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Calcimimetics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Hypercalcemia Treatment Market, By Indication, 2017 - 2028, (US$ Million)

  • Overview
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Primary Hyperthyroidism
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Hypercalcemia of Malignancy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)

7. Global Hypercalcemia Treatment Market, By Distribution Channel, 2017 - 2028, (US$ Million)

  • Overview
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)

8. Global Hypercalcemia Treatment Market, By Region, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2028
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Million)
    • UK
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Million)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2028, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

    • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Pfizer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Dr. Reddy's Laboratories Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Viatris Inc. (Mylan N.V.)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Sun Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Cipla Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Actiza Pharmaceutical Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Apotex Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Crinetics Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Alkem Labs
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Torrent Pharmaceuticals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Glenmark Pharmaceuticals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Hikma Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Slate Run Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us